![]() ![]() The drug is not available on the PBS and will cost around $3,000 per course. The drug is given intravenously as two consecutive infusions over five to ten minutes, or as a bolus injection, according to the TGA, and is now available in Australian hospitals. It will not reverse the effect of other newer anticoagulants, such as rivaroxaban and apixaban. ![]() Idarucizumab, (Praxbind), is a monoclonal antibody that reverses the anticoagulant effect by binding specifically to dabigatran (Pradaxa). The first reversal agent for the novel oral anticoagulant dabigatran has been approved by the TGA ![]()
0 Comments
Leave a Reply. |